ACADIA Pharmaceuticals Inc. (ACAD) Stock Quote

Detailed Quote for ACADIA Pharmaceuticals Inc. (ACAD)

After Hours: $ 1.74

-0.06 (-3.33%)

Volume: 500

4:02 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

April 26, 2011

Close: 3.30

52 Week Low

October 4, 2011

Close: 0.90

Today

Last Price
1.80

Change $
0.01

Change %
0.55%

Tick
N/A

Bid
N/A

Bid Size
0

Ask
N/A

Ask Size
0

Open
1.78

High
1.81

Low
1.77

Prev Close
1.81

Last Trade
2/10/12

Volume
429.22 k

52 Wk Hi
3.30

52 Wk Low
0.90

Market Cap
95.04 m

Ex-Div Date
N/A

Div Rate
N/A

Yield
N/A

Shares
52,800,919

EPS (TTM)
0.42

PE Ratio
4.30

close Exchange Information Listed On NASDAQ (NSD) Exchange
NSD

News and Media for ACADIA Pharmaceuticals Inc. (ACAD)

Sector News | Topic News

News for ACAD

Mon, Feb 06, 2012

9:00 AM

ACADIA Pharmaceuticals to Present at the 14th Annual BIO CEO & Investor Conference on February 13, 2012 - Business Wire

Mon, Jan 30, 2012

9:00 AM

ACADIA Pharmaceuticals Announces Election of Bill Wells to Its Board of Directors - Business Wire

Wed, Dec 07, 2011

9:00 AM

ACADIA Pharmaceuticals to Present at the Oppenheimer 22nd Annual Healthcare Conference on December 14, 2011 - Business Wire

Mon, Jan 10, 2011

11:52 AM

ACADIA Pharmaceuticals Inc. (ACAD) Secures $15 Million to Advance Pimavanserin Phase III Program - Accesswire

11:51 AM

ACADIA Pharmaceuticals Inc. (ACAD) Secures $15 Million to Advance Pimavanserin Phase III Program - Accesswire

More News for ACAD >>

Tags for ACADIA Pharmaceuticals Inc.

Research stocks or mutual funds related to ACADIA Pharmaceuticals Inc. by keywords or tags. Find companies that have a similar focus to ACAD. The keywords below have been associated to ACAD by either user submission or electronic means.

biotech research pharmaceuticals research pharmaceutical market pharmaceuticals companies generic pharmaceutical pharmaceuticals logistics pharmaceutical investment europe pharmaceuticals dupont pharmaceuticals pharma marketing pharmaceuticals germany pharma manufacturing novartis pharmaceuticals european pharmaceutical clinical research pharmaceutical cro biopharmaceutical companies pharma companies overactive immune system Anxiety disorder pharmaceutical sales pharma biotech corporation pharmaceutical development pharmaceutical reports biopharmaceutical company pharmaceutical magazine biotech biotechnology research worldwide clinical trials Drugs cranial sacral therapy pharmaceutical industry news pharmaceutical manufacturing software physical therapy occupational therapy chiropractic care pharmaceutical manufacturing neurologist disorders nervous system contract pharmaceutical pharmaceutical consulting autonomic nervous system pharmaceutical industry biotech contract pharmaceutical sale biopharmaceutical market pharm industry clinical trials europe pharmaceutical studies